Tag: #Global Trends

Novartis has unveiled its strategy to establish a radioligand therapy (RLT) manufacturing center in Denton, Texas. This facility represents the... Read more

Swiss pharmaceutical giant Roche is injecting 710 billion won (approximately $484 million) into South Korea’s biopharma sector. This investment aims... Read more

On March 4, 2026, Fujifilm Biotechnologies introduced ShunzymeX, a precision purification technology designed to streamline downstream processing for complex biologics.... Read more

In a last-minute breakthrough just days before a scheduled jury trial, Moderna has agreed to a settlement worth up to... Read more

On March 3, 2026, Teva Pharmaceuticals and Blackstone Life Sciences announced a $400 million strategic funding agreement to accelerate the... Read more

On March 4, 2026, Antengene Corporation and UCB entered into a global licensing agreement worth up to $1.18 billion to... Read more

Sanofi has entered into a significant $1.53 billion global licensing agreement with Sino Biopharmaceutical for rovadicitinib, a first-in-class dual JAK/ROCK... Read more

Moderna has resolved a protracted legal battle by agreeing to a $950 million upfront settlement with Genevant and Arbutus Biopharma.... Read more

German conglomerate Bayer has outlined its 2026 business outlook, characterizing it as the final year of a "resilience phase" before... Read more